3LBA Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study

Publication date: February 2017
Source:European Journal of Cancer, Volume 72, Supplement 1
Author(s): A. Necchi, J. Bellmunt, R. De Wit, D. Vaughn, Y. Fradet, J.L. Lee, L. Fong, N. Vogelzang, M. Climent, D. Petrylak, T. Choueiri, W. Gerritsen, H. Gurney, D. Quinn, S. Culine, C. Sternberg, Y. Mai, M. Puhlmann, R. Perini, D. Bajorin




http://ift.tt/2kKXxfo